Novartis AG (NVS)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 109.93 |
| Open | 110.04 |
| Bid | 110.40 x 800 |
| Ask | 113.55 x 800 |
| Day's range | 109.67 - 110.66 |
| 52-week range | 92.19 - 112.48 |
| Volume | |
| Avg. volume | 1,372,341 |
| Market cap | 223.99B |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | 22.56 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.78 (3.42%) |
| Ex-dividend date | 07 Mar 2024 |
| 1y target est | N/A |
- Zacks
Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?
On Incyte's (INCY) second-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its lead drug, Jakafi, which has been facing stiff competition.
- Zacks
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Zacks
Ionis (IONS) Completes Enrolment for Rare Disease Drug Study
Ionis' (IONS) late-stage study is evaluating zilganersen in a rare neurological disorder called Alexander disease. Top-line data from this study is expected by the end of the next year.
© 2024 Yahoo. All rights reserved.